End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
114,400 KRW | -1.97% |
|
-1.12% | -8.84% |
06-10 | FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A | CI |
05-20 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
939M | ||||||
796B | ||||||
628B | ||||||
358B | - | - | - | - | ||
331B | ||||||
301B |